Chemomab Therapeutics Ltd. Current Derivative Financial Liabilities
Chemomab Therapeutics Ltd. (CMMB) had Current Derivative Financial Liabilities of $6.97 million as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2019-04-24
- 2018-12-31: Current Derivative Financial Liabilities $6.97M.
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2018-12-31 | $6.97M 20-F · filed 2019-04-24 |